Videos uploaded by user “Proactive Investors Stocktube”
Plug Power CEO says fuels cells will soon dominate electric vehicles
Plug Power Inc (NASDAQ:PLUG) CEO Andy Marsh tells Proactive Investors the fuel cell manufacturer, whose customers include Amazon (NASDAQ:AMZN) and Walmart (NYSE:WMT), says in the next five years, fuels cells will begin to dominate electric vehicles like forklifts, delivery vans, and other vehicles on the road for eight to 15 hours a day. The Latham, New York company replaces lead acid batteries to power electric vehicles with hydrogen fuel cells. Marsh says investors should expect news flow from the company in the next six months indicating the company would be deploying vehicles on the road with some "good partners."
Namaste Technologies addresses recent challenges as they look to grow in the future
Namaste Technologies (CVE:N) Interim CEO Meni Morim and Chief Strategies Officer Darren Gill joined Proactive Investor's Steve Darling from Toronto to provide a corporate update on Namaste after a series of corporate changes. Morim addressed the recent parting of ways with the company's auditors and what the focus of Namaste is going forward. Gill told Proactive about their recent move in acquiring 49 percent of Choklat and how this first in to their new model at Namaste.
CannTrust Holdings Inc approved to uplist to NYSE
CannTrust Holdings Inc (OTCMKTS:CNTTF) (TSE:TRST) CEO Peter Aceto tells Proactive Investors the Canadian-based cannabis company has been approved to list on the New York Stock Exchange, under the ticker CTST. Aceto says the company decided to uplist now because the company is increasing its product breadth as well as its global expansion. It's important for the future success of the company and its investor base to be as global as its patient and customer base, he says.
Seelos Therapeutics shares soar on acquisition of Parkinson's candidate license created at UCLA
Seelos Therapeutics Inc (NASDAQ:SEEL) CEO Dr. Raj Mehra tells Proactive Investors the company has acquired an exclusive license to the rights to a potential Parkinson’s disease therapy created by researchers at the University of California, Los Angeles. Mehra said the therapy, known as SLS-007, may slow the progression of Parkinson's disease. He said the company may soon perform studies in mice. Shares of the New York-based biotech rose more than 40% on Friday.
Danakali “shovel-ready” at Colluli following execution of US$200m debt finance mandate
Danakali Ltd (ASX:DNK) (LON:DNK) executive chairman Seamus Cornelius updates Proactive Investors on the potash developer’s recent execution of a mandate to provide fully underwritten debt finance facilities of US$200M to fund and construct its Colluli Potash Project in Eritrea. “Given that we’re in Africa, if you were to take a market that is a specialist in funding African projects then that is probably London,” says Cornelius regarding Danakali’s recent AIM-listing. He continues, “getting the debt now with $200 million under the mandate letter, that helps us as well. “Where we are in terms of the project is we are shovel-ready, so as soon as we secure the full funding we will start construction – the construction will take two years and then we’ll be in production [in] 2021.”
Bulls, Bears & Brokers: Tony Locantro on Australia's housing market woes
Tony Locantro, stock market commentator and investment manager at Alto Capital, speaks to Proactive Investors about Australia's troubled housing market, reflecting on house prices and trends in earlier decades. "This generation has really lucked out and it's the baby boomers that bought, say pre-95, that have had a lotto-style win from sitting on their backsides," says Locantro. He continues, "People believe we're in this new paradigm of permanently high prices and someone said that before the 1929 crash. "I think Australia is going to deleverage - we have our debt relative to income at only 190%, that is probably the highest debt level on the planet, and all we're doing is buying rubbish items to impress people we don't like."
Graphite demand 'about to enter a period of rapid growth and improving prices'
Roskill's Kerry Satterthwaite and Suzanne Shaw discuss with Proactive Investors their Natural & Synthetic Graphite Global Industry, Markets & Outlook 2018 report. They say rapid growth in demand for natural flake graphite and synthetic graphite in the lithium-ion battery industry is now forecast to underpin total graphite demand growth of 5–7% per year between 2017 and 2027.
RNC Minerals unearths possibly biggest ever gold-rich stones in Australia
Mark Selby, President and CEO of RNC Minerals (TSE:RNX) spoke to Proactive London's Andrew Scott after announcing the first specimen slab from the top of the Father's Day Vein discovery area has been recovered at their Beta Hunt Mine in Western Australia. Selby says the slab, weighing around 90kg, is thought to contain approximately 1,000 ounces of gold. RNC reckons the gold-rich stones are among the biggest of their kind ever unearthed in Australia. 'We think we've made one of the great gold discoveries of this decade .. if not this century so far'', Selby says.
Melius Research: Nelson Peltz signing on to Aurora Cannabis is a 'good move'
Melius Research Founding Partner Rob Wertheimer joined Proactive Investors in the New York studio today to talk about the equity research company beginning coverage of the cannabis sector and trends he sees in the industry. Wertheimer says Aurora Cannabis Inc (NYSE: AC) adding billionaire activist investor Nelson Peltz as an advisor is a good move, as the savvy deal-maker will likely help the cannabis giant make deals and alliances.
The Green Organic Dutchman sees a path forward to become a player in the U.S.
The Green Organic Dutchman (TSE:TGOD) CEO Brian Athaide joined Steve Darling from Proactive Investors to discuss TGOD’s strategic investment into the US beverage space as a co-founding investor and strategic partner in the newly formed Califormulations LLC Athaide explains why they decided to do this and how this will fit into the Green Organic Dutchman’s growth strategy moving forward.
Sirius Minerals PLC chief discusses DFS and York Potash financing
The long-awaited definitive feasibility study (DFS) for Sirius Minerals PLC's (LON:SXX) York Potash Project in North Yorkshire has underscored its huge potential. The report says its net present value today is US$15bn using a 10% discount rate. Managing Director, Chris Fraser, tells Proactive that the firm is “ready to go” on construction of the project, with the company now looking to how it will finance its development. He adds that the projects biggest competitive advantage is its margins, with the company expecting “around 70% margins up to 85% - and it’s very difficult to find projects or companies that come even close to those margins.”
Lightwave Logic working to make the internet faster and more energy efficient
Lightwave Logic Inc (OTCMKTS:LWLG) CEO Michael Lebby joined Proactive's Andrew Scott at the Spring Investor Summit 219 in New York City. Lightwave is developing materials and devices for optical datacom and telecom hardware suppliers
iAnthus updates investors on activities in six US states
iAnthus Capital Holdings (CSE:IAN, OTCQB:ITHUF) CEO Hadley Ford tells Proactive Investors the cannabis company, which owns, operates and partners with licensed cannabis operations throughout the US, has expanded licensed cannabis cultivation operations, processing and dispensary facilities into six states. Ford updated investors on iAnthus's activities in all six states, and referenced the company's recent groundbreaking on its 39,500 sq. ft. medical cannabis cultivation and processing facility in Warwick, New York. Ford will be presenting to investors at Proactive Investor's CannaJam™ 2018 conference in New York, on September 12.
Tim Collins calls Andrew Left the 'Bond villain' of the financial world
Proactive Investors Contributor Tim Collins says notorious short-seller Citron Research's Andrew Left is a Bond villain for suggesting investors short-sell cannabis company Village Farms International Inc (NASDAQ:VFF) (TSE:VFF) targeting it at $1. Collins argues Left's attempted take-down of the company is for shock value, and uses unsubstantial accusations.
The Green Organic Dutchman achieves first commercial product sales in Canada
The Green Organic Dutchman Holdings Ltd's (TSE:TGOD) (OTCMKTS:TGODF) VP of Marketing Andrew Pollock tells Proactive Investors the cannabis company has begun shipping several hundred kilograms of cannabis to a national network of medical patients, marking a major milestone in the company’s production strategy. Pollock says the feedback from consumers has been 'terrific' and TGOD will be working with patients on a regular cadence to fulfill the group's orders.
Valens GroWorks takes major step forward with with release of record Q-1 Earnings
Valens GroWorks (CSE VGW-OTC:VGWCF) Executive VP of Strategy and Investments Everett Knight joined Steve Darling from Proactive Investors Vancouver on Skype to talk about Valens record earnings in Q-1 of 2019. Knight talked about what has gone right for the company so far in 2019. Knight also addressed their latest extraction deal and how it is another example of how the company is setting themselves up for the future.
Metalla Royalty & Streaming Ltd lays out 2019 portfolio plans
Metalla Royalty & Streaming Ltd (CVE:MTA) CEO Brett Heath tells Proactive Investors the Vancouver-based company's bulk of its portfolio is in development, Heath saying these development assets will drive the growth over the next year. Heath adds within the company's portfolio, two to four more of its companies will be in production this year. Heath plans to continue investments into North America within the tier 1 mining jurisdiction.
Antibe Therapeutics is a potential game changer in pain management
Antibe Therapeutics (CVE:ATE, OTCQB:ATBPF) CEO Dan Legault joined Steve Darling from Proactive Investors Vancouver to talk about a biotech company with a pipeline of drugs targeting pain and inflammation. Antibe's pipeline addresses significant unmet medical needs, especially concerning the safety and addictive properties of today's pain therapeutics. Legault also chatted with Proactive about a recently published paper in the British Journal of Pharmacology, providing extensive information about the successful Phase 2B safety trial for its lead drug.
Admedus COO encouraged by initial results from Phase II herpes vaccine trial
Admedus Ltd's (ASX:AHZ) chief operating officer Julian Chick talks to Proactive Investors on the interim Herpes Simplex Virus Phase II clinical trial data. The blinded trial provided data from the first 20 patients to receive at least three vaccinations in the randomised, placebo–controlled HSV-2 vaccine Phase II study. Chick says he is “very encouraged” by the first set of results, which shows the study is “going in the right way and we are seeing what we want to see”.
The Green Organic Dutchman signs hemp extraction deal with Valens GroWorks
The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCQX:TGODF) VP of Marketing Andrew Pollock tells Proactive Investors the company has struck a multi-year extraction services contract with Valens GroWorks Corporation (CSE:VGW) (OTCMKTS:VGWCF). Pollock says TGOD hopes to be ready with a product in Canada by early Q3 2019.
Glint reintroducing gold as money with launch of 'world first' payments app
Ben Davies, co-founder of Glint, spoke to Proactive as they launched their debit card and app (Glint Pay) which allows consumers to pay for goods and services with gold. The fintech group's teamed up with Lloyds Banking Group to create the app which allows people to load credit onto their card which can then be used to buy part of a physical piece of gold. Glint is regulated by the Financial Conduct Authority (FCA).
InMed Pharmaceuticals disrupting cannabinoid space with biosynthesis technology
InMed Pharmaceuticals Inc (TSX:IN; OTCQX:IMLFF) Chief Business Officer Josh Blacher speaks with Proactive Investor's Christine Corrado about how the biopharma company is changing the game in the cannabinoid space. Blacher says the Vancouver based company, which specializes in developing therapeutics to treat a variety of diseases, is disrupting the space with its cannabinoid biosynthesis technology, which aims to manufacture any of the more than 90 variations of cannabinoids, resulting in products that are bio-identical to the naturally occurring cannabinoids in the cannabis plant.
Tim Collins: Village Farms International's agricultural know-how sows success
Proactive Investors Contributor Tim Collins says Village Farms International Inc (OTCMKTS:VFFIF) (TSE:VFF) has the agricultural background to become a major player in the cannabis grow space. Collins says he doesn't think the stock, which was just approved to uplist to the Nasdaq and was trading north of $7 in the US, is expensive at the moment. He expects volatility for the entire cannabis industry.
EXRO Technologies looks to disrupt with Dynamic Power Management Technology
"Exro Technologies Inc (OTCQB:EXROF) CEO Mark Godsy sat down with Proactive Investors at the LD Micro Conference in New York. The Vancouver-based company develops the technology behind rotating electrical machines, from cars and buses to cranes and wind turbines."
Lupuzor could treat a number of diseases, says creator
Sylvaine Muller, creator of ImmuPharma PLC’s (LON:IMM) lead drug candidate Lupuzor, tells Proactive Investors the treatment is “unique” in its treatment for auto-immune disease lupus, as it only targets only the autoimmune system, and not the immune system. But, she adds, “we think that we can open up the indications in which the peptide [molecule] could be effective”. “We have already started some experiments,” Mulller says, which will target a range of diseases including inflammatory, chronic, those related to autoimmunity and those that aren’t - like asthma. “We have first indication that are extremely promising also in these indications,” she adds.
How to Invest in Mining: Proactive Investors presents a beginners guide
In the first of a series of “How to” videos, Proactive Investors presents a beginners guide to investing in the mining sector. Featuring Amanda Van Dyke, Women in Mining; Jeremy Wrathall, Investec and Niall Pearson, Hybridan.
Green Organic Dutchman gets green light from Hamilton City council to operate facility
The Green Organic Dutchman (TSE:TGOD) Vice President of Government Affairs and Social Responsibility Ian Wilms joined Steve Darling from Proactive Investors on Skype from Ontario to talk about their settlement with Hamilton City Council in regards to their facility in Ancaster, Ontario. Wilms talked about what this means for TGOD and also talks about the timeline going forward.
Here's what CannTrust needs to do to hit $10, says Bob Byrne
Proactive Investors contributor Bob Byrne says he believes CannTrust Holdings Inc (TSE:TRST) (OTCMKTS:CNTTF) is a cannabis company to watch. Byrne says the stock is cheap at about $6 compared to bigger cannabis stocks like Tilray (NASDAQ:TLRY ). Byrne says for the stock to move above $10, the Canntrust needs to uplist to a major US exchange and secure the necessary permits to complete the buildout of its Ontario, Canada facility.
Zelda Therapeutics poised to 'value add all the way from clinical trials to the market'
Dr Richard Hopkins, the newly appointed managing director of Zelda Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF), talks Proactive Investors through the medical cannabis researcher's recent strategic review, and provides updates on the company's three current clinical trials. In its efforts to commercialise by bringing products to global markets as rapidly as possible, Zelda will focus on downstream integration, in contrast with many peer companies that are integrating upstream into cannabis cultivation. Clinical trials are still at the centre of Zelda's operations. Currently there are trials ongoing for: opioid reducing pain management with St Vincent’s Hospital in Melbourne; insomnia with one of Australia’s leading sleep research centres; and paediatric patients with autism at the Children's Hospital of Philadelphia in the US.
GeoVax Labs developing a therapy that potentially cures Hepatitis B
GeoVax Labs Inc. (OTCQB:GOVX) Chairman & CEO David Dodd sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco. The clinical-stage biotechnology company is developing human vaccines against infectious diseases using its Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform.
WeedMD expands production with 25 acre outdoor cannabis cultivation
WeedMD (CVE:WMD-OTCQX:WDDMF) CEO Keith Merker joined Proactive Investors Vancouver's Steve Darling from Toronto with news the cannabis company is applying to expanded their Strathroy licence to 25 acres of outdoor cultivation. In 2019, Phase I will be brought online, representing more than 25 acres of production, with an additional 25 acres planned for Phase II in 2020.
Danakali chairman updates on financing with construction to start  before year-end
Seamus Cornelius, executive chairman of Danakali Ltd (ASX:DNK) (LON:DNK) (OTCMKTS:SBMSF), caught up with Proactive London after agreeing a US$200 million syndicated loan facility to go towards construction of its Colluli Potash Project in Eritrea. The fully-underwritten loan facility led by African development financial institutions (DFIs) African Export-Import Bank and Africa Finance Corporation has a series of milestones Danakali must satisfy to qualify. Colluli has a massive ore reserve estimate of 1.1 billion tonnes grading 10.5% potassium oxide for 203 million tonnes of contained sulphate of potash equivalent.
Graphene set to change everything says Versarien boss
From 3-D printing to sport, ‘wonder material’ graphene is set to change how we live according to Versarien PLC (LON:VRS) boss and founder Neil Ricketts. This year alone Versarien has started to work with former Olympian Kristan Bromley to develop graphene-enhanced skeleton boards, CT Engineering on aero parts and print specialist Absolute Engineering for graphene-based inks. Ricketts though, tells Proactive this is just the start as the understanding of these new materials and their uses is still at its very formative stages. For Versarien, having completed its IPO, raised funds and on track to break even, it all adds to a great place to be currently he explains.
ContraVir Pharmaceuticals CEO excited to get Hepatitis B drug to patients in new study
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) CEO James Sapirstein tells Proactive Investors the bio-pharmaceutical company has just announced a new formula of its Hepatitis B drug tenofovir exalidex (TXL) and can start delivering the drug to patients in a dose-range finding study, looking to be in Phase 3 trials sometime in the near future. Sapirstein also updated investors on the New Jersey based company's other Hepatitis B vaccine treatment called CRV-431, saying the FDA approved the company's investigational new drug application (IND).
Exro Technologies shaking up the energy storage industry with artificial intelligence
Exro Technologies Inc (OTCQB:EXROF) CEO Mark Godsy sat down with Proactive Investors at the LD Micro Conference in New York. The Vancouver-based company develops the technology behind rotating electrical machines, from cars and buses to cranes and wind turbines.
Ceres Power hits significant milestones with two key strategic partners
Phil Caldwell, chief executive of Ceres Power Holdings PLC (LON:CWR), tells Proactive London's Andrew Scott they're expecting full-year revenues to more than double after hitting two key commercial milestones with partners Bosch and Weichai Power. Caldwell says revenues and other operating income are expected to reach £15mln in the year, up from £7mln in 2017.
Preveceutical prepares for the final stage of their Sol Gel program
Preveceutical (CNSX:PREV) Chief Research Officer Dr Harry Parekh joined Steve Darling from Proactive Investors Vancouver to talk about the companies progress in the development of their sol-gel. Parekh telling proactive the next step they are undertaking with human tissue. He also talked about the progress made in screening peptides isolated from Caribbean Blue Scorpion venom to help combat some of the most aggressive diseases where there exists unmet clinical need, such as cancer.
CelSci updates Phase 3 clinical trial of Advanced Head and Neck Cancer treatment
CEL-SCI Corporation (NYSE:CVM) CEO Geert Kersten sat down with Proactive Investors at the ThinkEquity Conference in New York. The Virginia-based biotech treats patients who are newly diagnosed with advanced primary squamous cell carcinoma of the head and neck with its drug Multikine before they receive surgery, radiation and/or chemotherapy.
CO2 GRO Inc revolutionizing outdoor plant growth strategies
CO2 GRO Inc (TSXV:GROW) CEO John Archibald updates Proactive's Christine Corrado at the MicroCap Conference in New York. The company is dedicated to increasing the growth of all indoor and outdoor value plants using our advanced CO2 technologies.
KushCo Holdings Inc moves into sustainable cannabis packaging
KushCo Holdings Inc (OTCQB: KSHB) CFO Jim McCormick tells Proactive Investors' Christine Corrado that the vertically integrated company that services the ancillary cannabis market is moving into sustainable packaging. McCormick says KushCo has joined the Sustainable Packaging Coalition, a membership-based collaborative focused on sustainable packaging solutions. KushCo's brands include Kush Supply Co., formerly known as "Kush Bottles," a subsidiary that distributes packaging, supplies, and accessories.
Eco Atlantic's Gil Holzman welcomes strong investor interest in US$17mln fundraise
Gil Holzman, chief executive of Eco Atlantic Oil & Gas Ltd (LON:ECO) (CVE:EOG), speaks to Proactive London's Andrew Scott after raising US$17mln of new funds to cover its participation in a possible expansion to the exploration drilling campaign offshore Guyana. Eco will now be able to fund its share of up to four additional exploration or development wells, perhaps indicating confidence among the joint venture partners ahead of the first phase of wells.
Aurora Cannabis offshoot Australis Capital making its mark in the US
Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) CEO Scott Dowty and CFO Michael Carlotti tell Proactive Investors the investment firm focused on the cannabis sector is making its mark in the US, saying the company's most recent investment was in its acquisition of California-based cannabis brand Mr. Natural Productions Inc. Australis is a spinoff of Aurora Cannabis (NYSE: ACB), and continues to work closely with the cannabis giant.
FAR Ltd turns to The Gambia as SNE oilfield approaches commercialisation milestone
FAR Ltd (ASX:FAR) managing director Cath Norman speaks to Proactive Investors about the oil and gas exploration company’s exciting advancements off the west coast of Africa. The company’s efforts are currently focused on The Gambia, and in particular on the Samo prospect. “Drilling an 800 million barrel prospect is large by any company standards... when you consider that at the moment we have a net 140 million barrels to our name in Senegal, and our market cap’s $500 million, it’s wonderful to think about what our market capitalisation could be after we’ve drilled this Gambian well and have access to maybe another 300 million barrels to FAR’s name. And we’ll have the results of that well by mid to late November at the latest, if we spud on October 1,” says Norman. FAR Ltd’s Senegalese operations are much more advanced, approaching a key milestone on the path to commercialisation. Norman explains, “we’ve got past the three principal hurdles of size, deliverability, and connectivity; so we understand everything about the oilfield now enough to progress to development. We are in a position today where we’ll be submitting the discoveries evaluation report to the government in about two weeks, which is a statement of commerciality, which I know a lot of our shareholders will be very pleased to see. And with that we’ll be progressively releasing some information about the final size for the development, and also the economics. The field will be developed in a phased development approach... we’ll be looking to get approval of our development plan by the end of this year, we’ll take the final investment decision in mid-2019, and then we’ve got an ambition to have first oil in about 2022.”
Bushveld Minerals 'still very undervalued' as earnings soar
Fortune Mojapelo, Bushveld Mineral Limited’s (LON:BMN) chief executive, believes the miner's first half numbers were good 'by any stretch'. He adds, however, that they were based on an average vanadium price of US$65 per tonne, whereas the current price is US$110 per tonne, which bodes well for the second half. Fundamentals for vanadium are also far stronger going forward than they have been in the past, he reckons. . Phase 3 expansion at the Vametco vanadium mine is commencing in earnest, while the group is also looking for new brownfield assets. A dividend policy should be in place by the end of the year, while a framework to highlight the value in the energy storage business is also planned. “The business is still very undervalued," believes Mojapelo.
ITM Power CEO on ‘massive’ hydrogen infrastructure market
Graham Cooley, the chief executive of hydrogen fuel specialist ITM Power (LON:ITM), speaks about the ‘massive’ markets in energy storage and refuelling. Cooley explains the advantages of hydrogen vehicles over traditional plug-in electric cars and why ITM’s product is unique.
Sproutly Canada adds senior beverage exec Michael Bellas to its board
Sproutly Canada Inc (OTCQB:SRUTF) CEO Keith Dolo tells Proactive Investors the Vancouver-based cannabis company is adding seasoned beverage executive Michael Bellas, CEO and founder of New York-based Beverage Marketing Company, to its board of directors. Dolo says Sproutly, which is already a licensed cannabis producer, is now positioning itself to take advantage of its "APP technology," which will allow the company to create a water-soluble cannabis solution that will then be used in beverages to sell in Canada.
The Market Maker; what they do and how they make a market
ishareinfo.tv, in association with Proactiveinvestors, speaks to a market maker about pricing, the practice of going long and short on a stock and the effects of economic data and company news on the direction of shares.
CytoDyn take major step forward filing trial protocol for HIV Monotherapy
CytoDyn (OTCQB:CYDY) CEO Nader Pourhassan joined Steve Darling from Proactive Investors Vancouver on Skype to bring news the company has filed to the FDA, the pivotal trial protocol for leronlimab as a monotherapy for HIV patients. Pourhassan also shared details about the work involved to get to this point and what the next stage is.
Rare Earths market analysis from Roskill
Why are Rare Earths increasingly important both to China and the rest of the world? How is supply and demand met and which processes are holding up that supply chain from functioning optimally? What about the importance of secondary supply and recycling? All these questions and more are put to Roskill's Rare Earth's analyst David Merriman, who brings Proactive London up to date about this fascinating growing market and why investors should be keeping a sharp eye on it.
Nextleaf first public company to be issued a patent for extraction and purification
NextLeaf Solutions (CSE:OILS) CEO Paul Pederson sat down with Steve Darling from Proactive Investors Vancouver to discuss Nextleaf being issued a patent by the United States Patent and Trade Office for the Company's proprietary process of extraction, refinement, and distillation of cannabinoids from marijuana and hemp. Pederson telling Proactive how huge this is for a small upstart company and what this means for them moving forward.